131 related articles for article (PubMed ID: 38388141)
1. Advancing parathyroid anatomy understanding through single-cell RNA sequencing in uremic secondary hyperparathyroidism.
Ben-Dov IZ
Kidney Int; 2024 Mar; 105(3):433-435. PubMed ID: 38388141
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing reveals transdifferentiation of parathyroid chief cells into oxyphil cells in patients with uremic secondary hyperparathyroidism.
Mao J; You H; Wang M; Ba Y; Qian J; Cheng P; Lu C; Chen J
Kidney Int; 2024 Mar; 105(3):562-581. PubMed ID: 38142040
[TBL] [Abstract][Full Text] [Related]
3. Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients.
Mao J; You H; Wang M; Ni L; Zhang Q; Zhang M; Chen J
Amino Acids; 2022 May; 54(5):749-763. PubMed ID: 35348903
[TBL] [Abstract][Full Text] [Related]
4. The oxyphil cell in abnormal parathyroid glands. A study of 114 cases.
Allen TB; Thorburn KM
Arch Pathol Lab Med; 1981 Aug; 105(8):421-7. PubMed ID: 6894851
[TBL] [Abstract][Full Text] [Related]
5. Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
Ritter C; Miller B; Coyne DW; Gupta D; Zheng S; Brown AJ; Slatopolsky E
Kidney Int; 2017 Nov; 92(5):1217-1222. PubMed ID: 28750928
[TBL] [Abstract][Full Text] [Related]
6. Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease.
Ding Y; Zou Q; Jin Y; Zhou J; Wang H
Int Urol Nephrol; 2020 Jan; 52(1):155-159. PubMed ID: 31686279
[TBL] [Abstract][Full Text] [Related]
7. The function of the parathyroid oxyphil cells in uremia: still a mystery?
Basile C; Lomonte C
Kidney Int; 2017 Nov; 92(5):1046-1048. PubMed ID: 29055426
[TBL] [Abstract][Full Text] [Related]
8. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings.
Takebayashi S; Hidai H; Chiba T; Takagi Y; Nagatani Y; Matsubara S
J Nucl Med; 1999 Nov; 40(11):1792-7. PubMed ID: 10565772
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomic analysis of chief and oxyphil cell nodules in refractory uremic hyperparathyroidism by iTRAQ coupled LC-MS/MS.
Li S; Mao J; Wang M; Zhang M; Ni L; Tao Y; Huang B; Chen J
J Proteomics; 2018 May; 179():42-52. PubMed ID: 29526777
[TBL] [Abstract][Full Text] [Related]
10. Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?
Lomonte C; Vernaglione L; Chimienti D; Bruno A; Cocola S; Teutonico A; Cazzato F; Basile C
Clin J Am Soc Nephrol; 2008 May; 3(3):794-9. PubMed ID: 18322048
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression by oxyphil and chief cells of human parathyroid glands.
Ritter CS; Haughey BH; Miller B; Brown AJ
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1499-505. PubMed ID: 22585091
[TBL] [Abstract][Full Text] [Related]
12. Oxyphil cell function in secondary parathyroid hyperplasia.
Tanaka Y; Funahashi H; Imai T; Seo H; Tominaga Y; Takagi H
Nephron; 1996; 73(4):580-6. PubMed ID: 8856255
[TBL] [Abstract][Full Text] [Related]
13. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
Szende B; Farid P; Végso G; Perner F; Kopper L
Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
[TBL] [Abstract][Full Text] [Related]
15. Involution of the parathyroid glands after renal transplantation.
Lewin E
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):363-71. PubMed ID: 12815332
[TBL] [Abstract][Full Text] [Related]
16. Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride.
Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
J Clin Pathol; 2011 Sep; 64(9):756-60. PubMed ID: 21565858
[TBL] [Abstract][Full Text] [Related]
17. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructure of human parathyroid cells in health and disease.
Cinti S; Sbarbati A
Microsc Res Tech; 1995 Oct; 32(2):164-79. PubMed ID: 8580510
[TBL] [Abstract][Full Text] [Related]
19. Functioning oxyphil cell adenoma in a patient with secondary hyperparathyroidism.
Misonou J; Ishikura H; Aizawa M; Ohira S
Acta Pathol Jpn; 1987 Aug; 37(8):1357-66. PubMed ID: 3314334
[TBL] [Abstract][Full Text] [Related]
20. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content.
Carpentier A; Jeannotte S; Verreault J; Lefebvre B; Bisson G; Mongeau CJ; Maheux P
J Nucl Med; 1998 Aug; 39(8):1441-4. PubMed ID: 9708524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]